Registry for managing Helicobacter Pylori infection in Europe

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to systematically register and analyze the treatment, diagnosis, and management strategies for adult patients infected with Helicobacter pylori across various outpatient clinics in Europe. By evaluating the efficacy and safety of different treatment regimens and their cost-effectiveness, the study seeks to improve clinical practices and reduce the incidence of related complications such as peptic ulcers and gastric cancer. The data collected will help inform European Consensus guidelines for better healthcare efficiency in managing this prevalent infection.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Infected adult patients by Helicobacter pylori

Exclusion Criteria:

Where it's running

• Medical University Wien
  Vienna, Austria Recruiting
• CHU de Charleroi, Charleroi
  Charleroi, Belgium Recruiting
• Medical University of Sofia
  Sofia, Bulgaria Recruiting
• University Hospital Merkur
  Zagreb, Croatia Recruiting
• Charles University Faculty of Medicine
  Prague, Czechia Recruiting
• Køge University Hospital
  Køge, Denmark Recruiting

Study contacts

• Principal investigator: Javier Pérez Gisbert, MD — Fundación de Investigación Biomédica - Hospital Universitario de La Princesa
• Study coordinator: Javier Pérez Gisbert, MD
• Email: javier.p.gisbert@gmail.com
• Phone: +34 913093911

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Carminal for H. pylori gastritis

  This trial will test if taking 30 ml daily of the Aloe vera–based supplement Carminal together with standard H. pylori therapy helps adults with H. pylori–positive gastritis heal their stomach lining better than standard therapy plus placebo.

  Recruiting at 2 sites Phase 2 Catalysis SL · Belgrade, Central Serbia and 1 other locations · NCT07179237

• How often H. pylori comes back and what affects its return.

  This project will follow adults aged 18–75 who were treated for H. pylori to see how often the infection returns and which eradication regimens lower that risk.

  Recruiting Sohag University · Sohag · NCT07045857

• Comparing vonoprazan-based dual and triple treatments with standard PPI triple therapy for H. pylori infection.

  We're testing whether vonoprazan-based dual or triple treatments clear H. pylori more effectively than the usual PPI triple therapy in adults who have never been treated for the infection.

  Recruiting Sohag University · Sohag · NCT07045688

• Registry for managing Helicobacter pylori infection in Argentina

  This study collects information from doctors in Argentina to see how well different treatments work for Helicobacter pylori infections and to find the best ways to use antibiotics responsibly.

  Recruiting University of Buenos Aires · Ciudad de Buenos Aires · NCT06579365

• Eradicating H. Pylori with Argon Plasma During Endoscopy

  This study is testing a new argon plasma treatment during endoscopy to see if it can safely get rid of H. pylori infections in patients who haven't been treated yet.

  Recruiting Brigham and Women's Hospital · Boston, Massachusetts · NCT06529159

• Screening and treating H. pylori to prevent gastric cancer in young adults

  This study is testing if screening and treating young adults for H. pylori can help prevent gastric cancer in people aged 30-34 in several European countries.

  Recruiting at 6 sites University of Latvia · Zagreb, City of Zagreb and 6 other locations · NCT06275204

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.